172 related articles for article (PubMed ID: 19356064)
1. Renal and hepatic transporter expression in type 2 diabetic rats.
Nowicki MT; Aleksunes LM; Sawant SP; Dnyanmote AV; Mehendale HM; Manautou JE
Drug Metab Lett; 2008 Jan; 2(1):11-7. PubMed ID: 19356064
[TBL] [Abstract][Full Text] [Related]
2. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity.
Cheng Q; Aleksunes LM; Manautou JE; Cherrington NJ; Scheffer GL; Yamasaki H; Slitt AL
Mol Pharm; 2008; 5(1):77-91. PubMed ID: 18189363
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.
Cherrington NJ; Slitt AL; Li N; Klaassen CD
Drug Metab Dispos; 2004 Jul; 32(7):734-41. PubMed ID: 15205389
[TBL] [Abstract][Full Text] [Related]
4. Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment.
Aleksunes LM; Augustine LM; Scheffer GL; Cherrington NJ; Manautou JE
Toxicology; 2008 Sep; 250(2-3):82-8. PubMed ID: 18640236
[TBL] [Abstract][Full Text] [Related]
5. Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury.
Aleksunes LM; Scheffer GL; Jakowski AB; Pruimboom-Brees IM; Manautou JE
Toxicol Sci; 2006 Feb; 89(2):370-9. PubMed ID: 16177239
[TBL] [Abstract][Full Text] [Related]
6. Effects of Honokiol on CYP450 Activity and Transporter mRNA Expression in Type 2 Diabetic Rats.
Wang J; Zhai T; Chen Y
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534510
[TBL] [Abstract][Full Text] [Related]
7. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
8. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.
Le Vee M; Lecureur V; Stieger B; Fardel O
Drug Metab Dispos; 2009 Mar; 37(3):685-93. PubMed ID: 19074973
[TBL] [Abstract][Full Text] [Related]
9. Effect of culture time on the basal expression levels of drug transporters in sandwich-cultured primary rat hepatocytes.
Tchaparian EH; Houghton JS; Uyeda C; Grillo MP; Jin L
Drug Metab Dispos; 2011 Dec; 39(12):2387-94. PubMed ID: 21865320
[TBL] [Abstract][Full Text] [Related]
10. Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2).
Tanaka Y; Chen C; Maher JM; Klaassen CD
Toxicol Sci; 2008 Jan; 101(1):171-8. PubMed ID: 17959626
[TBL] [Abstract][Full Text] [Related]
11. Influence of Orally Administered Borneol on the Expression of Hepatic Transporters in Rats.
Chen L; Liao L; Zhai T; Huang X; Chen Y
Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):103-109. PubMed ID: 30105488
[TBL] [Abstract][Full Text] [Related]
12. The altered renal and hepatic expression of solute carrier transporters (SLCs) in type 1 diabetic mice.
Xu C; Zhu L; Chan T; Lu X; Shen W; Gillies MC; Zhou F
PLoS One; 2015; 10(3):e0120760. PubMed ID: 25789863
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats.
Choudhuri S; Cherrington NJ; Li N; Klaassen CD
Drug Metab Dispos; 2003 Nov; 31(11):1337-45. PubMed ID: 14570765
[TBL] [Abstract][Full Text] [Related]
14. Age-associated differences in transporter gene expression in kidneys of male rats.
Xu YJ; Wang Y; Lu YF; Xu SF; Wu Q; Liu J
Mol Med Rep; 2017 Jan; 15(1):474-482. PubMed ID: 27909713
[TBL] [Abstract][Full Text] [Related]
15. Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics.
Prasad B; Johnson K; Billington S; Lee C; Chung GW; Brown CD; Kelly EJ; Himmelfarb J; Unadkat JD
Drug Metab Dispos; 2016 Dec; 44(12):1920-1924. PubMed ID: 27621205
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.
Naud J; Michaud J; Beauchemin S; Hébert MJ; Roger M; Lefrancois S; Leblond FA; Pichette V
Drug Metab Dispos; 2011 Aug; 39(8):1363-9. PubMed ID: 21525170
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.
Fallon JK; Smith PC; Xia CQ; Kim MS
Pharm Res; 2016 Sep; 33(9):2280-8. PubMed ID: 27356525
[TBL] [Abstract][Full Text] [Related]
19. Changes of Transporters and Drug-metabolizing Enzymes in Nephrotic Syndrome.
Dong Y; Gong L; Lu X; Ye M; Lin Y; Xie S; Zhang J; Zhou F; Tang L; Zou W; Liu M
Curr Drug Metab; 2020; 21(5):368-378. PubMed ID: 32394830
[TBL] [Abstract][Full Text] [Related]
20. Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics.
Wang L; Collins C; Kelly EJ; Chu X; Ray AS; Salphati L; Xiao G; Lee C; Lai Y; Liao M; Mathias A; Evers R; Humphreys W; Hop CE; Kumer SC; Unadkat JD
Drug Metab Dispos; 2016 Nov; 44(11):1752-1758. PubMed ID: 27543206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
